DEBRA BOGAR: Open Payments
NPI 1962039503 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 22 payments from 11 companies in 2025. Trend: 2023 $302 · 2024 $966 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 2 | $50 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Neos Therapeutics, LP | 1 | $16 |
Products named: MOUNJARO, INVEGA SUSTENNA, REXULTI, UZEDY, XHANCE, AUSTEDO XR, PREVNAR 20, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
